Authors


Ryan Farrington, PharmD, BCPS

Latest:

Maximizing Electronic Medical Records: The Electronic Medical Record Adoption Model and the Health-System Pharmacist

There is growing confidence that health information technology investments will begin to meet expectations.


Becky A. Briesacher, PhD

Latest:

Impact of Initial Days' Supply of Angiotensin II Receptor Blockers

For ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.


Shawn X. Sun, PhD

Latest:

Examining Part D Beneficiaries' Medication Use in the Doughnut Hole

The authors found that the Part D doughnut hole significantly reduced the use of medications for treating potentially disabling and life-threatening conditions, but increased out-of-pocket costs for Medicare beneficiaries.


Todd Cooperman, PharmD, RPh, PAHM

Latest:

Challenges and Opportunities with Oral Oncology Agents

Pharmacists can collaborate with oncologists to maximize patient outcomes through appropriate dispensing, side-effect monitoring, and adherence.



Hiangkiat Tan, BPharm, MS

Latest:

Real-World Dosing and Utilization of Ustekinumab Among Patients With Psoriasis

This study is an evaluation of the dosing patterns of ustekinumab among patients with psoriasis in a real-world setting.



Anna M. Roe, MSN, RN

Latest:

Infection Specialists and Pharmacists Share Responsibility for Ensuring Patient Safety

Collaboration Is a necessary component of successful compliance with USP , and technology can help.


Anita T. Shaffer

Latest:

Pomalidomide Labeled an Advance in Multiple Myeloma

The combination of pomalidomide and a steroid significantly improved outcomes for patients with multiple myeloma who have exhausted other novel therapies, marking what researchers say is a notable advancement for a sizable proportion of those treated for the disease.


Michael S. Monaghan, PharmD

Latest:

Lifestyle Modifications for Patients with Metabolic Syndrome

Pharmacists are in a unique position to inform patients about the various features and proper use of blood pressure monitors.


Julie Kelly, 2017 PharmD Candidate

Latest:

Going Above and Beyond as Pharmacists

Learn more about what it's like to work for a Walgreens specialty pharmacy.




Nicholas Karalis, RPh

Latest:

Bullied into Extinction

Government involvement may be required in order to keep corporate entities from bullying specialty pharmacies out of business.


The Center for Biosimilars Staff

Latest:

FDA OKs Biosimilar Adalimumab for Autoimmune Conditions

The FDA has approved Sandoz’s biosimilar adalimumab, Hyrimoz (adalimumab-adaz) for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn disease, ulcerative colitis, and plaque psoriasis.



Nicole Kruczek, BS Pharm

Latest:

Are PBMs the Big Bad Wolf?

Pharmacy benefit managers are a large part of our health care benefits, but do they bring value?


Jeffrey Fudin, PharmD, Amelia Persico, MBA

Latest:

Pain Management in End-Stage Renal Disease

Recently we have received an increasing number of requests for consults on patients undergoing hemodialysis (HD) or with end-stage renal disease (ESRD).



David Kim

Latest:

Liraglutide (Victoza): A Quick Guide for Pharmacists

What role does this medication play in diabetes therapy, and what are its clinical benefits, compared with competitors?


Jerry A. Barbee Jr, PharmD, BCPS, CPh, Glenn Schulman, PharmD, MS, BCPS, BCACP, BCGP, BCIDP

Latest:

What Are Treatment Approaches to Liver Cancer?

How to treat hepatocellular carcinoma is heavily influenced by the burden of disease at diagnosis.



Ronald Y. Fujimoto, DO

Latest:

Adherence With Lipid-Lowering, Antihypertensive, and Diabetes Medications

Adherence was examined among patients taking medications, individually and in combinations, to treat hypertension, hyperlipidemia, and/or diabetes.


Roger On, MD, FACC

Latest:

Hypertension Treatment Guidelines Update

Health care providers often encounter patients with high blood pressure, especially systolic, who come and go without proper treatment and eventually end up in the hospital with a heart attack, kidney failure, or a stroke.


Edana Holliday, PharmD

Latest:

Educational Pharmacogenetics Resources for Pharmacists

The utility of pharmacogenetic testing has exponentially increased within the past few years.


Hassan Fouayzi, MS

Latest:

Impact of Initial Days' Supply of Angiotensin II Receptor Blockers

For ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.



Younos Abdulsattar, PharmD, BCPS

Latest:

Working Outside the Dispensing Box: The Roles of the Medical Information Specialist and Medical Science Liaison

As medical information specialists and medical science liaisons, pharmacists use their drug expertise and clinical skills to serve as information providers


Pam Piotrowski, BSPharm, RPh, MBA

Latest:

Jack Dalton Named Market Health and Wellness Director of the Year

As Market Health and Wellness Director for Market 331 in Las Vegas, Nevada, Jack Dalton exceeds expectations.


Alex Novielli, PharmD

Latest:

Herpes Zoster: Talking Points on the New Vaccine for Patients

The pharmacist is in a key position to assess and communicate about a patient’s specific vaccine needs.